Economic Evaluation in the Journal of Clinical Oncology: Past, Present, and Future
- 9 February 2007
- journal article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (6) , 614-616
- https://doi.org/10.1200/jco.2006.10.1659
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Cost Effectiveness of Adjuvant Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast CancerJournal of Clinical Oncology, 2007
- A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/neu–Positive Breast CancerJournal of Clinical Oncology, 2007
- Do the Large Benefits Justify the Large Costs of Adjuvant Breast Cancer Trastuzumab?Journal of Clinical Oncology, 2007
- Decision Analysis for Prophylactic Cranial Irradiation for Patients With Small-Cell Lung CancerJournal of Clinical Oncology, 2006
- Models Support Prophylactic Cranial IrradiationJournal of Clinical Oncology, 2006
- Information Created to Evade Reality (ICER)PharmacoEconomics, 2006
- Optimizing Adjuvant Endocrine Therapy in Postmenopausal Women With Early-Stage Breast Cancer: A Decision AnalysisJournal of Clinical Oncology, 2005
- Cost-Utility Analysis of Preoperative Radiotherapy in Patients With Rectal Cancer Undergoing Total Mesorectal Excision: A Study of the Dutch Colorectal Cancer GroupJournal of Clinical Oncology, 2004
- Economics of Preoperative Radiotherapy With Total Mesorectal Excision: What Can We Learn From the Dutch Experience?Journal of Clinical Oncology, 2004
- Outcomes of Tamoxifen Chemoprevention for Breast Cancer in Very High-Risk Women: A Cost-Effectiveness AnalysisJournal of Clinical Oncology, 2002